These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 24304429)

  • 21. Factors Influencing the Appearance of Oxaliplatin-Induced Allergy.
    Nishihara M; Nishikura K; Morikawa N; Yokoyama S
    Biol Pharm Bull; 2017; 40(12):2105-2109. PubMed ID: 29199235
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hypersensitivity reactions to oxaliplatin and the application of a desensitization protocol.
    Gammon D; Bhargava P; McCormick MJ
    Oncologist; 2004; 9(5):546-9. PubMed ID: 15477639
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oxaliplatin hypersensitivity: evaluation, implications of skin testing, and desensitization.
    Wong JT; Ling M; Patil S; Banerji A; Long A
    J Allergy Clin Immunol Pract; 2014; 2(1):40-5. PubMed ID: 24565767
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hypersensitivity reactions to oxaliplatin: what nurses need to know.
    Bonosky K; Miller R
    Clin J Oncol Nurs; 2005 Jun; 9(3):325-30. PubMed ID: 15973843
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Single premedication dose of dexamethasone 20 mg IV before docetaxel administration.
    Chouhan JD; Herrington JD
    J Oncol Pharm Pract; 2011 Sep; 17(3):155-9. PubMed ID: 20447949
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Expression of allergic reactions to oxaliplatin].
    Arii D; Ikeno Y; Murooka K; Nojima M; Kidokoro A
    Gan To Kagaku Ryoho; 2012 Apr; 39(4):593-7. PubMed ID: 22504684
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preventive effect of pre-warming, hot compress, and pH adjustment in oxaliplatin-induced venous pain.
    Kawazoe H; Sumikawa S; Nakauchi K; Yakushijin Y; Yamamoto Y; Watanabe Y; Tanaka A; Araki H
    Int J Clin Pharm; 2017 Dec; 39(6):1291-1297. PubMed ID: 29027645
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hypersensitivity Reactions to oxaliplatin: incidence and management.
    Gowda A; Goel R; Berdzik J; Leichman CG; Javle M
    Oncology (Williston Park); 2004 Nov; 18(13):1671-5; discussion 1676, 1680, 1683-4. PubMed ID: 15648298
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Allergic reactions to oxaliplatin in a single institute in Japan.
    Ichikawa Y; Goto A; Hirokawa S; Kijima M; Ishikawa T; Chishima T; Suwa H; Yamamoto H; Yamagishi S; Osada S; Ota M; Fujii S
    Jpn J Clin Oncol; 2009 Sep; 39(9):616-20. PubMed ID: 19556337
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oxaliplatin-free interval as a risk factor for hypersensitivity reaction among colorectal cancer patients treated with FOLFOX.
    Mori Y; Nishimura T; Kitano T; Yoshimura K; Matsumoto S; Kanai M; Hazama M; Ishiguro H; Nagayama S; Yanagihara K; Teramukai S; Chiba T; Sakai Y; Fukushima M
    Oncology; 2010; 79(1-2):136-43. PubMed ID: 21150228
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Incidence of hypersensitivity reactions in patients on H1-receptor antagonists receiving oxaliplatin-based chemotherapy.
    Barrett C; Park SJ; Edmondson L; Monga D
    J Oncol Pharm Pract; 2022 Apr; 28(3):577-581. PubMed ID: 33789524
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hypersensitivity reactions associated with oxaliplatin and their clinical management.
    Toki MI; Saif MW; Syrigos KN
    Expert Opin Drug Saf; 2014 Nov; 13(11):1545-54. PubMed ID: 25307143
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oxaliplatin-induced hypersensitivity reaction: underlying mechanisms and management.
    Aroldi F; Prochilo T; Bertocchi P; Zaniboni A
    J Chemother; 2015 Feb; 27(2):63-6. PubMed ID: 25096819
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Effects of Prolonged Infusion on Reducing Oxaliplatin Hypersensitivity Reactions.
    Zhang X; Zhao Y; Zheng Y; Dong Y
    J Investig Allergol Clin Immunol; 2017; 27(1):65-66. PubMed ID: 28211349
    [No Abstract]   [Full Text] [Related]  

  • 35. Coadministration of 5% glucose solution and dexamethasone and oxaliplatin-related vascular pain grade: a case study.
    Okada Y; Kajiume S; Taniguchi T; Kimoto S; Ogawa Y; Kiba T
    Clin J Oncol Nurs; 2013 Oct; 17(5):554-5. PubMed ID: 24080056
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Peripheral neuropathy in colorectal cancer survivors: the influence of oxaliplatin administration. Results from the population-based PROFILES registry.
    Beijers AJ; Mols F; Tjan-Heijnen VC; Faber CG; van de Poll-Franse LV; Vreugdenhil G
    Acta Oncol; 2015 Apr; 54(4):463-9. PubMed ID: 25417732
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hypersensitivity and idiosyncratic reactions to oxaliplatin.
    Thomas RR; Quinn MG; Schuler B; Grem JL
    Cancer; 2003 May; 97(9):2301-7. PubMed ID: 12712487
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hypersensitivity reactions to oxaliplatin and other antineoplastic agents.
    Syrigou E; Syrigos K; Saif MW
    Curr Allergy Asthma Rep; 2008 Mar; 8(1):56-62. PubMed ID: 18377776
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The prognosis of patients with an allergic reaction in the treatment of mFOLFOX6 therapy].
    Okada N; Ishibashi K; Kuwabara K; Ishiguro T; Hatano S; Hokama N; Tajima Y; Ishii M; Kubota S; Chika N; Miyazaki T; Ishida H
    Gan To Kagaku Ryoho; 2009 Nov; 36(12):1985-7. PubMed ID: 20037299
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Efficacy of a Dexamethasone Dose Escalation Regimen with a Cumulative Dose for Preventing Oxaliplatin Hypersensitivity Reactions].
    Morii Y; Senaha H; Matsui S; Okawa K; Tsubaki M; Matzno S; Shimomura K; Nishida S
    Gan To Kagaku Ryoho; 2022 Jul; 49(7):769-773. PubMed ID: 35851348
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.